文献速递妇科

TIM-3基因遗传变异与表达水平与上皮性卵巢癌患者临床预后相关

Genetic variants and expression of the TIM-3 gene are associated with clinical prognosis in patients with epithelial ovarian cancer.
PubMed 文献 · Gynecol Oncol · 2020-07-19

纳入中国北方700例上皮性卵巢癌(EOC)患者与710名健康对照,检测TIM-3三个多态性位点,并对339例术后患者分析生存。TIM-3多态性与EOC发病风险无关,但rs10053538 CA+AA基因型者无进展生存期(PFS)与总生存期(OS)较CC基因型更差,且该基因型者TIM-3 mRNA表达更高。

要点

  • TIM-3多态性(rs10053538、rs10515746、rs1036199)与EOC发病风险均无关。
  • rs10053538 CA+AA基因型者PFS(HR=1.49)与OS(HR=1.57)均较CC基因型更差。
  • rs10053538 CA+AA基因型者EOC组织中TIM-3 mRNA表达显著高于CC基因型(P=0.006)。

核心结论

  • TIM-3多态性与EOC发病风险无关;rs10053538与TIM-3 mRNA表达水平可能与EOC患者临床结局相关。

研究设计与样本

  • 研究纳入中国北方700例EOC患者和710名健康对照,采用聚合酶链反应/连接酶检测反应(PCR-LDR)法对rs10053538、rs10515746和rs1036199进行基因分型。
  • 339例接受肿瘤细胞减灭术的患者有可用的生存数据;采用实时定量PCR(RT-qPCR)检测TIM-3表达水平,并使用Kaplan-Meier plotter数据库评估TIM-3在EOC患者中的预后价值。

主要发现

  • rs10053538 CA+AA基因型患者PFS较CC基因型更差(HR=1.49,95%CI=1.05-2.09,P=0.024),OS亦更差(HR=1.57,95%CI=1.09-2.26,P=0.017)。
  • RT-qPCR结果显示,rs10053538 CA+AA基因型EOC组织中TIM-3 mRNA表达水平显著高于CC基因型(P=0.006)。
  • Kaplan-Meier plotter数据库分析显示,TIM-3 mRNA高表达与EOC患者较短PFS显著相关(HR=1.57,95%CI=1.29-1.91,P<0.001),与较短OS亦显著相关(HR=1.31,95%CI=1.06-1.63,P=0.013)。

关键数值与推荐

  • rs10053538 CA+AA基因型 vs CC基因型:PFS的HR=1.49(95%CI=1.05-2.09,P=0.024),OS的HR=1.57(95%CI=1.09-2.26,P=0.017)。
  • rs10053538 CA+AA基因型EOC组织TIM-3 mRNA表达显著高于CC基因型(P=0.006)。
  • TIM-3 mRNA高表达 vs 低表达:PFS的HR=1.57(95%CI=1.29-1.91,P<0.001),OS的HR=1.31(95%CI=1.06-1.63,P=0.013)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Polymorphisms of T cell immunoglobulin and mucin domain-containing molecule 3 (TIM-3) were reported to be associated with cancer risk and patients' survival. This study aims to investigate the correlation of TIM-3 polymorphisms with susceptibility to epithelial ovarian cancer (EOC) and patients' outcomes. METHODS: A total of 700 EOC patients and 710 healthy controls from North China were included. The polymorphisms (rs10053538, rs10515746 and rs1036199) were genotyped using the polymerase chain reaction/ligase detection reaction (PCR-LDR) method. Survival data were available for 339 patients after cytoreductive surgery. The expression level of TIM-3 was detected by real-time quantitative PCR (RT-qPCR). The prognostic value of TIM3 in EOC patients was assessed using the Kaplan-Meier plotter database. RESULTS: The results showed that none of the TIM3 polymorphisms were associated with the risk of developing EOC. Patients with the rs10053538 CA + AA genotype had worse PFS and OS than those with the CC genotype (HR = 1.49, 95% CI = 1.05-2.09, P = 0.024 and HR = 1.57, 95%CI = 1.09-2.26, P = 0.017, respectively). The RT-qPCR results showed that the expression levels of TIM-3 mRNA in EOC tissues with the rs10053538CA + AA genotypes were significantly higher than those with the CC genotype (P = 0.006). Analysis using the Kaplan-Meier plotter database showed that high expression of TIM-3 mRNA was significantly associated with shorter PFS and OS in EOC patients (HR = 1.57, 95%CI = 1.29-1.91, P < 0.001 and HR = 1.31, 95% CI = 1.06-1.63, P = 0.013, respectively). CONCLUSIONS: TIM-3 polymorphisms were not associated with risk of developing EOC. Both rs10053538 and the expression level of TIM-3 mRNA may be associated with its clinical outcome in EOC patients.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Wu JL, Zhao J, Zhang HB, et al. Genetic variants and expression of the TIM-3 gene are associated with clinical prognosis in patients with epithelial ovarian cancer. Gynecol Oncol. 2020. PMID: 32694063. doi:10.1016/j.ygyno.2020.07.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。